Free Newsletter
New administration adds billions more for R&D
The Obama Administration clearly loves funneling new dollars into R&D, and that means billions of additional dollars for biomedical research.
In the next fiscal year beginning Oct. 1, the administration is proposing to spend $147.6 billion on R&D, $555 million higher than the current year. And that money would be supplemented with $20 billion in stimulus spending budgeted between now and the end of 2010.
These new funds are allowing the NIH to commit an additional $10 billion in biomedical research, lab improvements and new construction. And more than a billion dollars is being budgeted to get started on comparative effectiveness research.
"We in the science and technology community have done better than just about any other constituencies in the budget," said White House science adviser John Holdren. "We think that's good for the country, not just good for us."
- read the story from U.S. News & World Report
Related Articles:
Stimulus money to double cancer research grants
Stimulus money spurs biomedical research work
Stimulus bill provides source of new R&D funds
Comments
Please don't forget "Advanced Cell Technology"
thank you
Please don't forget "Advanced Cell Technology"
thank you
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: